Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005890
Disease: Body Height
Body Height 		0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0023508
Disease: White Blood Cell Count procedure
White Blood Cell Count procedure 		0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0205682
Disease: Waist-Hip Ratio
Waist-Hip Ratio 		0.100 GeneticVariation phenotype GWASCAT Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. 30239722 2019
CUI: C1305855
Disease: Body mass index
Body mass index 		0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C1305855
Disease: Body mass index
Body mass index 		0.100 GeneticVariation phenotype GWASCAT Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. 30239722 2019
CUI: C0006287
Disease: Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia 		0.100 GeneticVariation disease GWASCAT Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants. 30113228 2018
CUI: C0151526
Disease: Premature Birth
Premature Birth 		0.100 GeneticVariation phenotype GWASCAT Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants. 30113228 2018
CUI: C2985280
Disease: Blood Protein Measurement
Blood Protein Measurement 		0.100 GeneticVariation phenotype GWASCAT Co-regulatory networks of human serum proteins link genetics to disease. 30072576 2018
CUI: C2242456
Disease: thyroid function
thyroid function 		0.100 GeneticVariation phenotype GWASDB Meta-analysis of two genome-wide association studies identifies four genetic loci associated with thyroid function. 22494929 2012
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.080 AlteredExpression disease BEFREE Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. 29603574 2018
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.080 AlteredExpression disease BEFREE Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. 29603574 2018
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma 		0.080 AlteredExpression disease BEFREE Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. 29603574 2018
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.080 Biomarker disease BEFREE Thirteen other TGFβ regulators (Chordin, Chordin-like 1, Chordin-like 2, Differential screening-selected gene aberrative in neuroblastoma [DAN], Decorin, Endoglin, Follistatin-like 1, Follistatin-like 3, Follistatin-like 4, Noggin, α2 macroglobulin, TGFβ receptor 3, Von Willebrand factor C domain-containing 2) had little or no effect. 28500669 2017
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.080 GeneticVariation disease BEFREE Bone morphogenetic proteins (BMPs) are regulated by extracellular antagonists of the DAN (differential screening-selected gene aberrative in neuroblastoma) family. 28104757 2017
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.080 Biomarker disease BEFREE Thirteen other TGFβ regulators (Chordin, Chordin-like 1, Chordin-like 2, Differential screening-selected gene aberrative in neuroblastoma [DAN], Decorin, Endoglin, Follistatin-like 1, Follistatin-like 3, Follistatin-like 4, Noggin, α2 macroglobulin, TGFβ receptor 3, Von Willebrand factor C domain-containing 2) had little or no effect. 28500669 2017
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.080 GeneticVariation disease BEFREE Bone morphogenetic proteins (BMPs) are regulated by extracellular antagonists of the DAN (differential screening-selected gene aberrative in neuroblastoma) family. 28104757 2017
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma 		0.080 GeneticVariation disease BEFREE Bone morphogenetic proteins (BMPs) are regulated by extracellular antagonists of the DAN (differential screening-selected gene aberrative in neuroblastoma) family. 28104757 2017
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma 		0.080 Biomarker disease BEFREE Thirteen other TGFβ regulators (Chordin, Chordin-like 1, Chordin-like 2, Differential screening-selected gene aberrative in neuroblastoma [DAN], Decorin, Endoglin, Follistatin-like 1, Follistatin-like 3, Follistatin-like 4, Noggin, α2 macroglobulin, TGFβ receptor 3, Von Willebrand factor C domain-containing 2) had little or no effect. 28500669 2017
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.080 Biomarker disease BEFREE These data suggest that the RET molecules enable selective gene transduction, and that NBL-1 may possibly be applied to gene therapy for neuroblastomas and Parkinson's disease. 10811228 2000
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.080 AlteredExpression disease BEFREE Using a biotinylated NBL-1 complexed with plasmid DNAs based on electrostatic interaction through avidin-conjugated polylysines, exogenous luciferase genes were expressed in neuroblastoma cells at a more than 10-fold higher level. 10811228 2000
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma 		0.080 AlteredExpression disease BEFREE Using a biotinylated NBL-1 complexed with plasmid DNAs based on electrostatic interaction through avidin-conjugated polylysines, exogenous luciferase genes were expressed in neuroblastoma cells at a more than 10-fold higher level. 10811228 2000
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.080 Biomarker disease BEFREE The forced expression of DAN gene enhanced the neurite extension in the presence of RA, suggesting that DAN gene product might contain some regulatory role(s) in the RA-induced cellular differentiation in neuroblastoma cells. 9500977 1998
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma 		0.080 Biomarker disease BEFREE Down-regulation of protein kinase C alpha and gamma and enhanced TPA-induced neurite formation in DAN-transfected neuroblastoma cells. 9862417 1998
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.080 Biomarker disease BEFREE Down-regulation of protein kinase C alpha and gamma and enhanced TPA-induced neurite formation in DAN-transfected neuroblastoma cells. 9862417 1998
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma 		0.080 Biomarker disease BEFREE The forced expression of DAN gene enhanced the neurite extension in the presence of RA, suggesting that DAN gene product might contain some regulatory role(s) in the RA-induced cellular differentiation in neuroblastoma cells. 9500977 1998